Which hedge funds own CLDX? CELLDEX THERAPEUTICS INC NEW, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in CLDX (CELLDEX THERAPEUTICS INC NEW) in their Q2 2026 13F filings, worth $79.5m in total. The largest holder by portfolio weight is Suvretta Capital Management at 0.1% of its book. 1 manager opened a new position this quarter: Suvretta Capital Management. 1 exited: Tudor Investment.
6tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold CLDX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Suvretta Capital Management | Q2 2026 | 0.1% | $4.5m | 121,297 | – | new |
| Woodline Partners | Q2 2026 | 0.1% | $26.1m | 700,830 | 40% | added |
| Millennium Management | Q2 2026 | 0.0% | $43.6m | 1,170,787 | -7% | reduced |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $4.4m | 117,217 | -96% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $302.6k | 8,131 | -12% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $663.3k | 17,826 | -66% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Tudor Investment | 0.1% | $1.1m |
How has hedge fund ownership of CLDX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $79.5m |
| Q1 2026 | 7 | $167.5m |
| Q4 2025 | 3 | $64.6m |
| Q3 2025 | 4 | $111.7m |
| Q2 2025 | 3 | $91.2m |
| Q1 2025 | 4 | $72.4m |
| Q4 2024 | 4 | $118.7m |
| Q3 2024 | 2 | $132.9m |
| Q2 2024 | 3 | $101.4m |
| Q1 2024 | 4 | $101.3m |
| Q4 2023 | 3 | $125.3m |
| Q3 2023 | 3 | $40.5m |
| Q2 2023 | 3 | $42.9m |
| Q1 2023 | 4 | $73.7m |
| Q4 2022 | 3 | $117.3m |
| Q3 2022 | 5 | $68.3m |
Counts every tracked manager that disclosed CLDX in that quarter's filing, including managers that have since stopped filing.